Dual serotonergic signals: a key to understanding paradoxical effects?
暂无分享,去创建一个
[1] J. Homberg,et al. The role of serotonin in drug use and addiction , 2015, Behavioural Brain Research.
[2] Kenji F. Tanaka,et al. Optogenetic Activation of Dorsal Raphe Serotonin Neurons Enhances Patience for Future Rewards , 2014, Current Biology.
[3] T. Stürmer,et al. Antidepressant dose, age, and the risk of deliberate self-harm. , 2014, JAMA internal medicine.
[4] Adrian G. Fischer,et al. Neural mechanisms and temporal dynamics of performance monitoring , 2014, Trends in Cognitive Sciences.
[5] S. Shergill,et al. Ketamine as the prototype glutamatergic antidepressant: pharmacodynamic actions, and a systematic review and meta-analysis of efficacy , 2014, Therapeutic advances in psychopharmacology.
[6] Minmin Luo,et al. Dorsal Raphe Neurons Signal Reward through 5-HT and Glutamate , 2014, Neuron.
[7] P. Dayan,et al. Differential, but not opponent, effects of l-DOPA and citalopram on action learning with reward and punishment , 2013, Psychopharmacology.
[8] E. Bauer,et al. Acute and chronic effects of selective serotonin reuptake inhibitor treatment on fear conditioning: Implications for underlying fear circuits , 2013, Neuroscience.
[9] D. Javitt,et al. A randomized add-on trial of high-dose D-cycloserine for treatment-resistant depression. , 2013, The international journal of neuropsychopharmacology.
[10] A. Bortolozzi,et al. Selective siRNA-mediated suppression of 5-HT1A autoreceptors evokes strong anti-depressant-like effects , 2012, Molecular Psychiatry.
[11] P. Buckley. Looking on the Bright Side of Serotonin Transporter Gene Variation , 2012 .
[12] J. Ballenger. The Serotonin Transporter Promoter Variant (5-HTTLPR), Stress, and Depression Meta-analysis Revisited: Evidence of Genetic Moderation , 2012 .
[13] P. Kelly,et al. Mechanism of acute tryptophan depletion: is it only serotonin? , 2011, Molecular Psychiatry.
[14] K. Shedden,et al. The serotonin transporter promoter variant (5-HTTLPR), stress, and depression meta-analysis revisited: evidence of genetic moderation. , 2011, Archives of general psychiatry.
[15] H. Nijhout,et al. Bursts and the Efficacy of Selective Serotonin Reuptake Inhibitors , 2011, Pharmacopsychiatry.
[16] L. Descarries,et al. From glutamate co-release to vesicular synergy: vesicular glutamate transporters. , 2011, Nature reviews. Neuroscience.
[17] N. Daw,et al. Serotonin and Dopamine: Unifying Affective, Activational, and Decision Functions , 2011, Neuropsychopharmacology.
[18] Marc Laruelle,et al. Serotonin transporter polymorphisms (SLC6A4 insertion/deletion and rs25531) do not affect the availability of 5-HTT to [11C] DASB binding in the living human brain , 2010, NeuroImage.
[19] F. Fujiyama,et al. Vesicular glutamate transporter 3‐expressing nonserotonergic projection neurons constitute a subregion in the rat midbrain raphe nuclei , 2010, The Journal of comparative neurology.
[20] D. Popa,et al. A longitudinal study of 5-HT outflow during chronic fluoxetine treatment using a new technique of chronic microdialysis in a highly emotional mouse strain. , 2010, European journal of pharmacology.
[21] L. Lanfumey,et al. VGLUT3 (Vesicular Glutamate Transporter Type 3) Contribution to the Regulation of Serotonergic Transmission and Anxiety , 2010, The Journal of Neuroscience.
[22] Ahmad R. Hariri,et al. Cognitive impact of genetic variation of the serotonin transporter in primates is associated with differences in brain morphology rather than serotonin neurotransmission , 2009, Molecular Psychiatry.
[23] P. Dayan,et al. Opponency Revisited: Competition and Cooperation Between Dopamine and Serotonin , 2010, Neuropsychopharmacology.
[24] Z. Borhegyi,et al. Fast Synaptic Subcortical Control of Hippocampal Circuits , 2009, Science.
[25] P. Dayan,et al. Serotonin in affective control. , 2009, Annual review of neuroscience.
[26] J. W. Aldridge,et al. Dissecting components of reward: 'liking', 'wanting', and learning. , 2009, Current opinion in pharmacology.
[27] Markus Ullsperger,et al. Neuropharmacology of performance monitoring , 2009, Neuroscience & Biobehavioral Reviews.
[28] Kae Nakamura,et al. Reward-Dependent Modulation of Neuronal Activity in the Primate Dorsal Raphe Nucleus , 2008, The Journal of Neuroscience.
[29] Saori C. Tanaka,et al. Low-Serotonin Levels Increase Delayed Reward Discounting in Humans , 2008, The Journal of Neuroscience.
[30] C. Beyer,et al. Do selective serotonin reuptake inhibitors acutely increase frontal cortex levels of serotonin? , 2008, European journal of pharmacology.
[31] T. Robbins,et al. Serotoninergic regulation of emotional and behavioural control processes , 2008, Trends in Cognitive Sciences.
[32] M. Feenstra,et al. Serial reversal learning and acute tryptophan depletion , 2008, Behavioural Brain Research.
[33] J. Homberg,et al. Serotonin transporter deficiency in rats improves inhibitory control but not behavioural flexibility , 2007, The European journal of neuroscience.
[34] Alexander F. Wilson,et al. Genetic markers of suicidal ideation emerging during citalopram treatment of major depression. , 2007, The American journal of psychiatry.
[35] R. Joosten,et al. Medial prefrontal serotonin in the rat is involved in goal-directed behaviour when affect guides decision making , 2007, Psychopharmacology.
[36] Rebecca Elliott,et al. Citalopram modulation of neuronal responses to aversive face emotions: a functional MRI study , 2007, Neuroreport.
[37] Monika Liguz-Lecznar,et al. Vesicular glutamate transporters (VGLUTs): the three musketeers of glutamatergic system. , 2007, Acta neurobiologiae experimentalis.
[38] K. Deisseroth,et al. Circuit-breakers: optical technologies for probing neural signals and systems , 2007, Nature Reviews Neuroscience.
[39] A. Hariri,et al. Genetics of emotional regulation: the role of the serotonin transporter in neural function , 2006, Trends in Cognitive Sciences.
[40] T. Robbins,et al. Neurochemical Modulation of Response Inhibition and Probabilistic Learning in Humans , 2006, Science.
[41] Viktor Varga,et al. Serotonergic neuron diversity: identification of raphe neurons with discharges time-locked to the hippocampal theta rhythm. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[42] G. Marek,et al. The Selective 5-HT2A Receptor Antagonist M100907 Enhances Antidepressant-Like Behavioral Effects of the SSRI Fluoxetine , 2005, Neuropsychopharmacology.
[43] K. Deisseroth,et al. Millisecond-timescale, genetically targeted optical control of neural activity , 2005, Nature Neuroscience.
[44] G. Chouvet,et al. Effects of Acute and Long-Term Administration of Escitalopram and Citalopram on Serotonin Neurotransmission: an In Vivo Electrophysiological Study in Rat Brain , 2005, Neuropsychopharmacology.
[45] Christopher C Lapish,et al. Mesocortical Dopamine Neurons Operate in Distinct Temporal Domains Using Multimodal Signaling , 2005, The Journal of Neuroscience.
[46] T. Robbins,et al. Serotonergic Modulation of Prefrontal Cortex during Negative Feedback in Probabilistic Reversal Learning , 2005, Neuropsychopharmacology.
[47] M. Walton,et al. Differential involvement of serotonin and dopamine systems in cost-benefit decisions about delay or effort , 2005, Psychopharmacology.
[48] P. Blier,et al. Electrophysiological Evidence for the Tonic Activation of 5-HT1A Autoreceptors in the Rat Dorsal Raphe Nucleus , 2004, Neuropsychopharmacology.
[49] T. Robbins,et al. Cognitive Inflexibility After Prefrontal Serotonin Depletion , 2004, Science.
[50] L. Callado,et al. Effectiveness of pindolol plus serotonin uptake inhibitors in depression: a meta-analysis of early and late outcomes from randomised controlled trials. , 2004, Journal of affective disorders.
[51] Trevor Sharp,et al. Inhibition of median and dorsal raphe neurones following administration of the selective serotonin reuptake inhibitor paroxetine , 1995, Naunyn-Schmiedeberg's Archives of Pharmacology.
[52] J. Hornung,et al. The human raphe nuclei and the serotonergic system , 2003, Journal of Chemical Neuroanatomy.
[53] S. Hisano. Vesicular glutamate transporters in the brain , 2003, Anatomical science international.
[54] A. Caspi,et al. Influence of Life Stress on Depression: Moderation by a Polymorphism in the 5-HTT Gene , 2003, Science.
[55] R. Hen,et al. Effects of chronic paroxetine treatment on dialysate serotonin in 5‐HT1B receptor knockout mice , 2003, Journal of neurochemistry.
[56] Marco Cecchi,et al. Serotonin Clearance In Vivo Is Altered to a Greater Extent by Antidepressant-Induced Downregulation of the Serotonin Transporter than by Acute Blockade of this Transporter , 2002, The Journal of Neuroscience.
[57] D. Streiner,et al. Antidepressant and benzodiazepine for major depression. , 2002, The Cochrane database of systematic reviews.
[58] D. Streiner,et al. Antidepressants plus benzodiazepines for major depression , 2001 .
[59] J D Malley,et al. In vivo microdialysis assessment of extracellular serotonin and dopamine levels in awake monkeys during sustained fluoxetine administration , 2000, Synapse.
[60] F. Fadda,et al. A physiological method to selectively decrease brain serotonin release. , 2000, Brain research. Brain research protocols.
[61] John H Krystal,et al. Antidepressant effects of ketamine in depressed patients , 2000, Biological Psychiatry.
[62] J. Bizot,et al. Serotonin and tolerance to delay of reward in rats , 1999, Psychopharmacology.
[63] B. Kupelnick,et al. Effectiveness of antidepressants , 1999, British Journal of Psychiatry.
[64] C. Halldin,et al. Localization of 5-HT1A receptors in the living human brain using [carbonyl-11C]WAY-100635: PET with anatomic standardization technique. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[65] S. Stahl. Mechanism of action of serotonin selective reuptake inhibitors. Serotonin receptors and pathways mediate therapeutic effects and side effects. , 1998, Journal of affective disorders.
[66] I. Lucki,et al. The spectrum of behaviors influenced by serotonin , 1998, Biological Psychiatry.
[67] Barry J. Everitt,et al. Central 5-HT depletion enhances impulsive responding without affecting the accuracy of attentional performance: interactions with dopaminergic mechanisms , 1997, Psychopharmacology.
[68] I. Lucki,et al. Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine measured in vivo. , 1995, The Journal of pharmacology and experimental therapeutics.
[69] M. Hajós,et al. Interaction between a selective 5‐HT1A receptor antagonist and an SSRI in vivo: effects on 5‐HT cell firing and extracellular 5‐HT , 1995, British journal of pharmacology.
[70] C. Montigny,et al. Current advances and trends in the treatment of depression. , 1994, Trends in pharmacological sciences.
[71] Mark D. Johnson. Synaptic glutamate release by postnatal rat serotonergic neurons in microculture , 1994, Neuron.
[72] M. Virkkunen,et al. Aggression, suicidality, and serotonin. , 1992, The Journal of clinical psychiatry.
[73] Roberto Invernizzi,et al. Citalopram's ability to increase the extracellular concentrations of serotonin in the dorsal raphe prevents the drug's effect in the frontal cortex , 1992, Brain Research.
[74] S. Garattini,et al. Effects of short- and long-term administration of fluoxetine on the monoamine content of rat brain , 1992, Neuropharmacology.
[75] P. Molinoff,et al. Basic Neurochemistry: Molecular, Cellular and Medical Aspects , 1989 .
[76] P. Soubrié,et al. Effects of imipramine-like drugs and serotonin uptake blockers on delay of reward in rats. Possible implication in the behavioral mechanism of action of antidepressants. , 1988, The Journal of pharmacology and experimental therapeutics.
[77] M. Trulson. Dietary tryptophan does not alter the function of brain serotonin neurons. , 1985, Life sciences.
[78] J. Scuvée-Moreau,et al. Effect of various antidepressant drugs on the spontaneous firing rate of locus coeruleus and dorsal raphe neurons of the rat. , 1979, European journal of pharmacology.